Barely Significant
← all excerpts

Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma.

Nat Cancer · 2023 · PMC10212768 · PMID 37081258

Europe PMCDOI
1
hedged sentence
0.0076
closest p · 0.2× alpha
0.0076
boldest claim

The sentences

highly significantP = 0.00763actually significant
Kaplan–Meier analysis of all 34 patients showed highly significant increases in the time to next treatment for PCY-sensitive patients compared to PCY-resistant patients (log-rank P = 0.00763; hazard ratio (HR) = 4.57, 1.77–11.8 95% confidence interval (CI 95 )) (Fig. 8d ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.